Role of endothelin-1 in hypertension and vascular disease

被引:264
作者
Schiffrin, EL [1 ]
机构
[1] Clin Res Inst Montreal, Multidisciplinary Res Grp Hypertens, Montreal, PQ H2W 1R7, Canada
关键词
vascular remodeling; endothelin antagonists; mineralocorticoid; salt sensitivity; atherosclerosis;
D O I
10.1016/S0895-7061(01)02074-X
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Endothelin-1 (ET-1) is a powerful vasoconstrictor peptide and regulator of blood flow that plays an important role in blood pressure (BP) elevation in some models of experimental hypertension such as DOCA-salt rat, DOCA-salt-treated spontaneously hypertensive rats (SHR), stroke-prone SHR, Dahl salt-sensitive rats, angiotensin II-infused rats, and one-kidney, one-clip Goldblatt rats, but not in SHR, two-kidney, one-clip hypertensive rats, transgenic (mREN2)27 rats, or NO-nitro-L-arginine methyl ester chronically treated rats. In those models of hypertension in which ET-1 plays a vasoconstrictor role, ET-1 was shown to be overexpressed in the vessel walls, or BP has been lowered by administration of ETA/B- and ETA-selective receptor antagonists, In these experimental models, endothelin receptor antagonists also regressed vascular growth and inflammation, and improved endothelial dysfunction. Hypertensive rats treated with endothelin antagonists were protected from stroke and renal injury. In hypertensive rats without generalized vascular overproduction of ET-1, expression of ET-1 was often enhanced in intramyocardial coronary arteries, suggesting a role of ET in myocardial ischemia in hypertension. Moderate-to-severe hypertensive patients presented enhanced expression of pre-proET-1 mRNA in the endothelium of subcutaneous resistance arteries, suggesting that this stage of hypertension may respond particularly well to endothelin antagonism. In some hypertensive patients, exaggerated vascular responses to ET-1 were found. Hypertensive patients with coronary artery disease have increased arterial expression of ET-1. Increased plasma levels of immunoreactive ET have been described in African Americans. ET-1 plays an important role in atherosclerosis, for which hypertension is an important risk factor, and in ischemic heart disease and stroke. Endothdin-1 may also be involved in other forms of vascular disease, including pulmonary hypertension, after angioplasty restenosis, after allograft vasculopathy, and vasculitis. Thus, ET-1 may participate in vascular damage in cardiovascular disease and in BP elevation in experimental models and in human hypertension. Endothelin antagonists could become effective disease-modifying agents in different forms of cardiovascular disease. Am J Hypertens 2001;14:83S9S (C) 2001 American Journal of Hypertension, Ltd.
引用
收藏
页码:83S / 89S
页数:7
相关论文
共 85 条
[71]   Enhanced expression of the endothelin-1 gene in blood vessels of DOCA-salt hypertensive rats: Correlation with vascular structure [J].
Schiffrin, EL ;
Lariviere, R ;
Li, JS ;
Sventek, P .
JOURNAL OF VASCULAR RESEARCH, 1996, 33 (03) :235-248
[72]   ANTIHYPERTENSIVE EFFECT OF AN ENDOTHELIN RECEPTOR ANTAGONIST IN DOCA-SALT SPONTANEOUSLY HYPERTENSIVE RATS [J].
SCHIFFRIN, EL ;
SVENTEK, P ;
LI, JS ;
TURGEON, A ;
REUDELHUBER, T .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 115 (08) :1377-1381
[73]   Enhanced expression of endothelin-1 gene in resistance arteries in severe human essential hypertension [J].
Schiffrin, EL ;
Deng, LY ;
Sventek, P ;
Day, R .
JOURNAL OF HYPERTENSION, 1997, 15 (01) :57-63
[74]   DEOXYCORTICOSTERONE ACETATE PLUS SALT INDUCES OVEREXPRESSION OF VASCULAR ENDOTHELIN-1 AND SEVERE VASCULAR HYPERTROPHY IN SPONTANEOUSLY HYPERTENSIVE RATS [J].
SCHIFFRIN, EL ;
LARIVIERE, R ;
LI, JS ;
SVENTEK, P ;
TOUYZ, RM .
HYPERTENSION, 1995, 25 (04) :769-773
[75]   PLASMA ENDOTHELIN IN HUMAN ESSENTIAL-HYPERTENSION [J].
SCHIFFRIN, EL ;
THIBAULT, G .
AMERICAN JOURNAL OF HYPERTENSION, 1991, 4 (04) :303-308
[76]   Clinical significance of endothelin in cardiovascular disease [J].
Schiffrin, EL ;
Intengan, HD ;
Thibault, G ;
Touyz, RM .
CURRENT OPINION IN CARDIOLOGY, 1997, 12 (04) :354-367
[77]   ENDOTHELIN - POTENTIAL ROLE IN HYPERTENSION AND VASCULAR HYPERTROPHY [J].
SCHIFFRIN, EL .
HYPERTENSION, 1995, 25 (06) :1135-1143
[78]   BLUNTED EFFECTS OF ENDOTHELIN UPON SMALL SUBCUTANEOUS RESISTANCE ARTERIES OF MILD ESSENTIAL HYPERTENSIVE PATIENTS [J].
SCHIFFRIN, EL ;
DENG, LY ;
LAROCHELLE, P .
JOURNAL OF HYPERTENSION, 1992, 10 (05) :437-444
[79]   Vascular endothelin-1 expression and effect of an endothelin ETA antagonist on structure and function of small arteries from stroke-prone spontaneously hypertensive rats [J].
Sharifi, AM ;
He, G ;
Touyz, RM ;
Schiffrin, EL .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1998, 31 :S309-S312
[80]   Apoptosis in aorta of deoxycorticosterone acetate salt hypertensive rats: effect of endothelin receptor antagonism [J].
Sharifi, AM ;
Schiffrin, EL .
JOURNAL OF HYPERTENSION, 1997, 15 (12) :1441-1448